For PwC, ops and business strengths drive PRTM buy

Drug process and regulatory expert PRTM will be acquired by global consultancy PricewaterhouseCoopers. PRTM will join the PwC global advisory practice, among the world's largest consultancies. PwC cites operational strategy, execution and business model innovation among PRTM's strengths, which were no doubt attractive also to drugmaker Ranbaxy when it hired the consultancy to help extricate itself from regulatory hot water. Announcement

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.